Equillium, Inc.

As of June 30, 2026, Equillium, Inc. carries a market capitalization of 173.74M, placing it among publicly traded companies globally. Its enterprise value stands at 124.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Equillium, Inc.'s next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, Equillium, Inc. has 63.41M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Equillium, Inc. maintains a current ratio of 23.40, meaning it holds 23.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Equillium, Inc. posted a negative return on equity (ROE) of -58.98, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -50.68, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 19.25, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Equillium, Inc.'s stock has gained approximately 0.35% over the past 52 weeks. The 50-day moving average sits at 1.65, while the 200-day moving average is 1.81.

Over the twelve months ended June 30, 2026, Equillium, Inc. generated - - in revenue and converted that into -15.76M in net income, yielding earnings per share of -0.17. EBITDA reached -16.81M, while operating income came in at -16.90M.

As of June 30, 2026, Equillium, Inc. holds 50.04M in cash and equivalents against 511,175.20 in total debt, resulting in a net debt position of -50.04M. Total book value stands at 49.03M, with working capital of 48.58M providing operational flexibility.

Equillium, Inc. produced -17.48M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -103,285.40 in capital expenditures, free cash flow totaled -17.58M - equivalent to -0.19 per share.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -7.03: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -33.12, meaning Equillium, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Equillium, Inc. has an Altman Z-Score of 39.59, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.